Background. Ureaplasmas have been inconsistently associated with nongonococcal urethritis (NGU). We evaluated the association of the newly differentiated species Ureaplasma urealyticum (UU) and Ureaplasma parvum (UP) with NGU using 2 separate control groups.
transmitted disease (STD) clinics where attendees have similar characteristics and past exposures, potentially hampering detection of an association [22] . An alternate explanation lies in findings from recent phylogenetic analyses that demonstrate that the 2-biovar system of classification represents 2 distinct species, now designated Ureaplasma parvum (UP; formerly U. urealyticum biovar 1) and U. urealyticum (UU; formerly U. urealyticum biovar 2) [23, 24] . Although indistinguishable by conventional culture methods, UU and UP can be differentiated by polymerase chain reaction (PCR) [24] [25] [26] [27] [28] . Genotypic and phenotypic differences between these species are an emerging area of research; markers associated with pathogenic potential have not yet been identified [23, 25, [29] [30] [31] [32] . Moreover, the epidemiologic data regarding associations of differentiated UU and UP with NGU are inconclusive [28, [33] [34] [35] .
We conducted a case-control study using 2 separate control groups to investigate the associations of UU and UP with NGU overall and in prespecified subgroups. We hypothesized that UU, but not UP, would be associated with NGU and that the relationship would be stronger when men who were not STD clinic attendees were compared with case patients (vs the standard STD clinic control subjects). Because we hypothesized that adaptive immunity might attenuate clinical manifestations of infection, we evaluated the associations of UU and UP with NGU among younger men and those with less sexual experience. We posited that the relationships would be stronger among these men.
MATERIALS AND METHODS

Study Population
A total of 754 men $16 years of age participated in this casecontrol study in Seattle, Washington, from May 2007 through October 2009. Men who received a diagnosis of urethral gonococcal infection on the basis of positive gram-stain smear results, men who had used antibiotics within the past month, and men with known allergies to tetracyclines or azithromycin were not eligible to participate.
The case group was drawn from a pool of 370 STD clinic patients enrolled in an NGU treatment trial. These men had visible urethral discharge on examination and/or $5 polymorphonuclear neutrophils (PMNs) per high-powered field (HPF; 10003) averaged over $3 fields (hereafter abbreviated as $5 PMNs/HPF) on a urethral gram-stained smear. The 38 case patients with a visible discharge but ,5 PMNs/HPF were excluded from the present analysis, as were 3 case patients with urethral gonococcal infection detected by culture and by urine transcription-mediated amplification assays after enrollment, yielding a final sample of 329 case patients. The characteristics of the case group have been previously described [36] .
One control group consisted of 191 men without NGU who attended the STD clinic for reasons other than NGU (ie, STD screening, human immunodeficiency virus [HIV] testing, or evaluation and treatment for genital ulcers or warts; hereafter abbreviated STD control subjects). Another group of 193 control subjects were recruited from the emergency department (ED) waiting area at the same medical center. This group included ED patients typically seeking care for minor injuries and male friends and family members (hereafter abbreviated ED control subjects). All control subjects had no detectable urethral discharge and ,5 PMNs/HPF on a gram-stained smear.
All study procedures were approved by the University of Washington Human Subjects Division, and written informed consent was obtained from all participants.
Data Collection
Men with suspected NGU and control subjects were referred to a single study clinician who collected symptom data and comprehensive sexual histories. A computer-assisted self-interview collected supplemental medical history and behavioral data. A routine STD examination included detailed inspection of the genitalia and collection of a urethral swab sample and 25-30 mL of first-void urine. The urethral swab sample was used to prepare a gram-stained smear to quantitate PMNs and identify gram-negative intracellular diplococci indicative of gonococcal infection. Urine was tested for the following organisms: Neisseria gonorrhoeae and Chlamydia trachomatis (CT), using APTIMA Combo 2 assay (Gen-Probe); Trichomonas vaginalis (TV), using research-use only APTIMA TV analyte-specific reagents (GenProbe) [37] ; MG, using an in-house PCR [38] ; and ureaplasmas by culture (indicated by a color change from yellow to red within 1 week of incubation in U broth) [39] . An additional aliquot of urine was frozen at 270°C and later used to reculture ureaplasmas in batches with daily monitoring to preserve viability. These cultures were subsequently speciated using in-house UU-and UP-specific PCR assays [27, 40] . Men with negative ureaplasma culture results were classified as negative for UU and UP. Ureaplasma cultures were not available for speciation procedures for 14 men (7 case patients, 3 STD control subjects, and 4 ED control subjects). Specimens from another 18 men (9 case patients, 3 STD control subjects, and 6 ED control subjects) had color changes in U broth typical of ureaplasma growth but were negative by UU and UP PCR assays. These 32 men were considered ureaplasma positive but unspeciated, and they were therefore excluded from the species-specific analyses of UU and UP. The MG PCR assay was inhibited for 3 case patients and 1 ED control subject. Complete laboratory results were available for the other organisms of interest. Laboratory personnel were blinded to case or control status.
Statistical Analyses
Sociodemographic, behavioral, and clinical characteristics of study subjects were summarized by case status. Categorical characteristics were compared using Pearson's v 2 tests and Fisher's exact tests. Continuous data were compared across groups using 2-sample t tests and Wilcoxon rank-sum tests. We summarized prevalences of organisms detected in urine by selfreported sexual preference (defined by the sex of sex partners from the previous year) and by case status. Associations of CT, MG, TV, UU, and UP with NGU were evaluated bivariately using logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs). We used multivariable logistic regression to assess the associations of UU and UP with NGU, adjusting for the potential confounding effects of important sociodemographic and clinical characteristics (ie, age, race, prior NGU, prior gonococcal infection, and detection of other pathogens). Because NGU is relatively rare in the underlying population at risk, the resultant adjusted ORs (aORs) closely approximate relative risks. We also performed a series of prespecified subgroup analyses. In one, we restricted case patients to those with symptoms or signs consistent with urethritis (ie, complaints of discharge or dysuria, or visible discharge) in addition to microscopic evidence of urethral inflammation (ie, $5 PMNs/HPF). In another, we evaluated associations of UU and UP with NGU among men ,30 years of age. Finally, to explore the influence of lifetime sexual experience on the associations of interest, we stratified our sample by the numbers of lifetime vaginal, insertive anal, and insertive oral sex partners. Specifically, for vaginal and oral sex, we compared the associations of UU and UP with NGU among men reporting $10 lifetime partners to those among men reporting ,10 partners. Because study participants reported fewer insertive anal sex partners overall, our strata cutoff point for analyses of insertive anal sex was lower (ie, 5 partners). To further explore potential dose-response relationships, we also estimated these associations among men with even fewer lifetime partners. In these stratified models, we also adjusted for numbers of other types of partners (for example, when evaluating associations among men with ,10 lifetime vaginal partners, we controlled for numbers of insertive anal and insertive oral partners). Because we did not ask about the sex of all lifetime sex partners, we adjusted for the sex of sex partners within the past 2 months to control for unmeasured exposures associated with the sex of sex partners.
To assess the impact of control selection on study findings, for all models, we compared the associations of UU and UP with NGU identified when case patients were compared with STD control subjects to those identified when ED control subjects served as the comparison group.
In sensitivity analyses, we assessed the degree to which the observed associations of UU and UP with NGU might have been biased because of the exclusion from the main analysis of the 32 ureaplasma culture-positive men for whom speciated ureaplasma results were not available, under conditions of extreme differential misclassification. We refit the full and stratified multivariable models twice, once assuming all case subjects were positive for UU and UP whereas all control subjects were negative, and again assuming all case subjects were negative for UU and UP whereas all control subjects were positive. Analyses were performed using STATA statistical software, version 11.1 (StataCorp). Two-sided tests were used, and the level of significance was set at P 5 .05.
RESULTS
Among all men (n 5 713), the mean age was 34.7 years (range, 16.2-72.1 years). Most subjects identified themselves as white (52.3%) or black (33.2%) race, 5.9% reported Hispanic ethnicity, and 23.7% reported sex with men within the past year. Most case patients reported attending the clinic for symptoms (76.0%), whereas most STD control subjects sought STD screening (91.6%) ( Table 1) .
STD control subjects and ED control subjects differed significantly with respect to self-reported sociodemographic characteristics, behaviors, and histories. STD control subjects were significantly younger than ED control subjects (mean age, 34.4 vs 36.8 years; P 5 .03) and were much less likely to report black race (14.1% vs 48.7%; P , .001) and earning ,$10 000 per year (26.1% vs 55.2%; P , .001). STD control subjects were much more likely to report having any male sex partners within the previous year, compared with ED control subjects (30.9% vs 5.2%; P , .001). Although STD control subjects were more likely to report a history of NGU, compared with ED control subjects (10.8% vs 1.1%; P , .001), they were significantly less likely to report a history of gonococcal infection, compared with ED control subjects (14.1% vs 25.9%; P 5 .004).
Differences in sociodemographic characteristics, behaviors, and histories by case-control status were also detected, and the direction of these differences frequently depended on the source of the control group. Compared with STD control subjects, case patients were more likely to report black race and low income, but compared with ED control subjects, they were less likely to report these traditional sexually transmitted infection risk factors. Case patients reported greater numbers of partners within the 2 months prior to the interview and were more likely to report any new or male partners, compared with ED control subjects. In contrast, the sexual behaviors reported by case patients and STD control subjects were similar with one exception: STD control subjects were somewhat more likely to report a new recent sex partner, compared with case patients. All groups reported similar numbers of vaginal sex partners over the course of their lifetime. History of NGU and prior chlamydial infection were associated with case status, irrespective of the comparison group. However, the differences were more marked when case patients were compared with ED control subjects. In contrast, case patients and ED control subjects were equally likely to report prior gonococcal infection, whereas significantly fewer STD control subjects reported this characteristic.
Overall, CT was detected in 85 men (11.9%), MG was detected in 49 (6.9%), and TV was detected in 12 (1.7%). In Median no. of lifetime insertive anal sex partners (IQR)
Among men reporting only male partners in the past year
Among men reporting only female partners in the past year
Clinical presentation contrast, ureaplasmas were cultured from urine specimens provided by 290 participants (40.7%). Among the 681 men with speciated ureaplasma results (313 case patients, 185 STD control subjects, and 183 ED control subjects), UU and UP were identified in 150 (22.0%) and 120 (17.6%), respectively. Ureaplasma coinfections were rare (12 of 681; 1.8%). The prevalences of urethral organisms detected among study participants differed markedly by sexual preference (Table 2) . UU and UP were detected among 25.5% and 22.8% of men reporting sex with women within the past year, yet they were detected in only 14.2% and 1.5% of men who had only male sex partners within the past year (P 5 .006 and P , .001, respectively, for these comparisons). CT was detected significantly more often among men with only male sex partners within the past year, and MG was detected somewhat more often among this group. TV was detected exclusively among men reporting female sex partners, but differences were not significant because of sparse data.
The prevalences of urethral organisms also differed by case or control status. In bivariate analyses (Table 3) , detection of significant associations of UU and UP with NGU depended on the choice of comparison group. UU was significantly associated with NGU when case patients were compared with STD control subjects (OR, 1.6; 95% CI, 1.04-2.6), but not when case patients were compared with ED control subjects (OR, 1.3; 95% CI, 0.8-2.0). In contrast, no association was observed between UP and NGU when case patients were compared with other STD clinic attendees (OR, 0.8; 95% CI, 0.5-1.2), and a significant inverse association was detected when case patients were compared with ED control subjects (OR, 0.5; 95% CI, 0.3-0.8). As expected, CT and MG were strongly associated with NGU, irrespective of the comparison group, with greater magnitude when case patients were compared with STD control subjects. TV was infrequently detected but was associated with NGU when case patients were compared with ED control subjects.
In multivariable models adjusting for age, race, prior NGU, prior gonococcal infection, and detection of other pathogens, UU was marginally associated with NGU (aOR STD-control , 1.6 [95% CI, 0.9-2.8]; P 5 .104; aOR ED-control , 1.7 [95% CI, 0.97-3.0]; P 5 .066) ( Table 4) . UP was not associated with NGU in the aggregate multivariable models. The absence of significant associations of UU and UP with NGU in our multivariable models persisted even after restricting our case patient group to men with symptoms or signs in addition to microscopic evidence of urethral inflammation and when restricting the study sample to men ,30 years of age.
In sub-analyses assessing the effect of lifetime sexual experience, we detected no associations between ureaplasmas and NGU among men with $10 lifetime vaginal sex partners (Table 4 
]).
Estimates from all stratified multivariable models were similar when the 32 ureaplasma culture-positive men lacking speciated ureaplasma results were included and models were re-fit under both conditions of extreme differential misclassification (data not shown).
DISCUSSION
UU was the most frequently detected organism among men with NGU in this study, yet it was identified only somewhat more often among case patients than among control subjects. Row categories are not mutually exclusive. Among 713 study participants, 59 men (8.7%) had .1 organism detected. Thirty-six men reported no sex partners within the previous year (3 case patients, 7 STD control subjects, and 26 ED control subjects). Among these men, no CT, MG, TV, or UU infections were detected. UP was detected in 1 STD control subject who reported no sex partners within the previous year.
Abbreviations: CT, Chlamydia trachomatis; MG, Mycoplasma genitalium; TV, Trichomonas vaginalis; UP, Ureaplasma parvum; UU, Ureaplasma urealyticum. a Includes 26 men who reported sex with both women and men within the previous year.
UP was also frequently detected among men with NGU, but the prevalence of this organism was even higher among control subjects. In unadjusted analyses, UU was significantly associated with NGU when case patients were compared with other STD clinic attendees without NGU, but not when case patients were compared with men recruited from an ED waiting area. Despite important differences in the sociodemographic characteristics and histories reported by men in each of our comparison groups, adjustment for these potential confounders produced similar measures of association of UU with NGU when case patients were compared with either control group. In aggregate multivariable analyses, the association of UU with NGU was marginal. These marginal associations, albeit modest in comparison with the relationships of CT and MG with NGU, were strengthened after restricting our analysis to men with fewer lifetime sex partners, but not of younger age. Our findings are consistent with the hypothesis that adaptive immunity attenuates the clinical manifestation of UU infection; repeated or prolonged exposure to UU via multiple sex partners may result in asymptomatic infection without signs of urethral inflammation. There was no positive association between UP and NGU, which suggests that UP is not a urethral pathogen.
Four previous case-control studies have evaluated the associations of UU and UP with urethritis in men [28, [33] [34] [35] . Three of these studies detected UU significantly more often among case patients [28, 33, 34] . However, the largest epidemiologic study to date detected this species somewhat more often among control subjects, although the difference was not statistically significant [35] . In all 4 of these investigations, UP was detected more frequently among control subjects. In 2 studies, this difference was significant [28, 35] and remained significant in 1 of these studies even after adjustment for age, race, prior urethritis, and the presence of CT, MG, or TV [28] . Coinfection with UU and UP was uncommon in each of these previous investigations [28, [33] [34] [35] .
Although our results are largely consistent with previous casecontrol studies of differentiated ureaplasma species and NGU, our study differed from these investigations in several important ways. We incorporated quantification of urethral PMNs into our eligibility criteria for case patients and control subjects (as did the 3 studies that detected UU significantly more often among case patients [28, 33, 34] ); however, the only study to detect UU more often among control subjects enrolled participants with and without acute urethral symptoms but did not require case patients to have signs of urethritis (only 57% had urethral discharge, and 42% had $5 PMNs/HPF) and did not obtain urethral swab specimens from control subjects to rule out asymptomatic urethritis [35] . In addition, although prior urethritis and possibly age are important proxy variables for previous exposures to sexually transmitted organisms, our results demonstrate that adjustment for age and history of urethritis alone is not sufficient to tease out the complicated relationships between ureaplasmas and NGU. The detailed survey data that All multivariable models adjust for age, race, prior NGU, prior gonococcal infection, and detection of other pathogens (Chlamydia trachomatis, Mycoplasma genitalium, or Trichomonas vaginalis). Models stratified by number of lifetime sex partners also adjust for numbers of other types of lifetime partners (ie, models stratified by number of vaginal partners are adjusted for numbers of insertive anal and insertive oral partners, models stratified by number of insertive anal partners are adjusted for numbers of vaginal and insertive oral partners, and models stratified by number of insertive oral partners are adjusted for numbers of vaginal partners and insertive anal partners) to isolate the effects of each type of sexual experience on the relationships of U. urealyticum and U. parvum with NGU. All models stratified by numbers of lifetime sex partners also adjust for the sex of sex partners in the previous 2 months to control for potential confounding due to unmeasured exposures associated with sex partner sex. Two model-specific sample sizes are displayed for each multivariable model (case patients compared with STD control subjects, and case patients compared with ED control subjects).
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; ED, emergency department; STD, sexually transmitted disease. a Case patients with symptoms or signs of NGU in addition to $5 polymorphonuclear leukocytes per high-powered field (n 5 294).
augmented our standard clinical histories allowed us to more explicitly account for patient-level characteristics, such as lifetime sexual experience. Although it is possible that our UU/UP detection algorithm could be biased toward the detection of a single species among men with mixed infections following the primary culture enrichment, our preliminary experiments demonstrated improved sensitivity when the UU/UP PCRs were applied to the monitored ureaplasma cultures rather than the urine specimen processed for PCR (data not shown), possibly because of the greater volume of urine used for culture (0.5 mL), compared with that used for PCR (25 lL) .
Existing data from the late 1970s support our hypothesis that first exposure to ureaplasmas, specifically UU, produces a more exuberant inflammatory response than does subsequent exposure. An early human challenge experiment demonstrated that, among 2 men, repeated intraurethral inoculation with these ureaplasmas ceased to result in symptomatic infection after the fourth round despite colonization [41] . In addition, one of the first case-control studies to evaluate the association between undifferentiated ureaplasmas and urethritis also observed a stronger relationship between ureaplasmas and urethritis among men with less sexual experience [6] . In that analysis, ureaplasmas were detected in 81% of CT-negative case patients with NGU and in 58% of control subjects. However, among men who reported #5 lifetime sex contacts, ureaplasmas were identified in 92% of CT-negative case patients with NGU, compared with just 23% of control subjects. Previous investigators posited that the failure of some studies to detect an association between undifferentiated ureaplasmas and NGU might be explained by high carriage rates among study populations consisting of sexually active male STD clinic attendees who became tolerant to ureaplasma infection [12] . Ureaplasmas have previously been described as common commensal bacteria in humans [42] and are frequently detected in persons without evidence of overt disease. Undifferentiated ureaplasmas have been detected in cervical or vaginal specimens in 40%-80% of asymptomatic women [43] [44] [45] [46] , in urethral or urine specimens from 20%-60% of otherwise healthy sexually active male college students living in fraternity houses [47] , and, in our study, in 34% of STD clinic attendees without NGU and 42% of men without NGU recruited from an ED waiting area. Although our data suggest that UP does not cause urethritis in men and that prior exposure to UU may dampen the inflammatory response to subsequent UU infections, the clinical effect of repeated or prolonged exposure to UU is not known.
This work demonstrates that the association of ureaplasmas with NGU depends on the species detected as well as the sexual experience of the population under study. Future studies should incorporate quantitative data on ureaplasma load, along with detailed sexual history data. Use of quantitative PCR assays [48] to assess the association between bacterial load and signs and symptoms of disease would support the role of UU in the etiology of NGU if such a relationship is found. In addition, studies assessing the relationship of local and/or humoral antibodies to signs and symptoms of UU infection might shed light on the pathogenesis of infection.
In conclusion, we found that urethral infections with UU and UP were extremely common in men with and without clinically apparent urethritis, the association of UU with NGU was statistically significant only among men with fewer lifetime sex partners, and the magnitude of this association was dwarfed by that for either CT or MG. Whether asymptomatic ureaplasma infections result in ongoing transmission to female partners and whether these infections result in important pathology in men or women remains uncertain. However, given the very high prevalence of UU and UP, even a relatively low level of pathogenicity may have important public health implications. Because diagnostic tests for differentiated ureaplasmas are not currently available outside of research settings, data demonstrating the effectiveness of standard NGU therapies for combating these infections, including data being collected in our ongoing NGU treatment trial, may inform the management of men with NGU and their sex partners. More data regarding associations of UU, and perhaps UP, with serious morbidity in men and women is necessary to determine the extent to which successful eradication of these organisms from men with or without clinically apparent urethritis should be prioritized.
